Gilteritinib monotherapy for relapsed/refractory FLT3 mutated acute myeloid leukemia: a real-world, multi-center, matched analysis - Concepedia

Concepedia

Publication | Closed Access

Gilteritinib monotherapy for relapsed/refractory FLT3 mutated acute myeloid leukemia: a real-world, multi-center, matched analysis

20

Citations

19

References

2022

Year

Shai Shimony, Jonathan Canaani, Eitan Kugler, Boaz Nachmias, Ron Ram, Israel Henig, Avraham Frisch, Chezi Ganzel, Vladimir Vainstein, Yakir Moshe,

Annals of Hematology

Hematological MalignancyGilteritinib MonotherapyOncologyMixed-phenotype Acute LeukemiaAcute Myeloid LeukemiaHematologyMyeloid NeoplasiaMedicineRadiation OncologyRelapsed/refractory Flt3Cancer ResearchHealth Sciences

References

	Year	Citations

Page 1

Page 1